Reuters logo
BRIEF-Cytokinetics says it entered into controlled equity offering sales agreement
November 6, 2017 / 11:13 AM / 15 days ago

BRIEF-Cytokinetics says it entered into controlled equity offering sales agreement

Nov 6 (Reuters) - Cytokinetics Inc:

* On Nov 3, entered into controlled equity offering sales agreement to sell shares of common stock, with offering price of up to $75 million Source text : (bit.ly/2znfoQg) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below